According to him, the first and second phases of the tests show that 100% of the subjects developed immunity on the 21st day after vaccination, after the second attempt it doubles. TASS… Dmitriev noted that the director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Ginzburg, and the deputy director for research, Denis Logunov, who are involved in the project of this vaccine, are very thoroughly testing the drug.
Russia will publish all data on the vaccine in August, said the head of the RDIF. However, more than 20 countries have already expressed interest in a Russian-developed vaccine, and five countries plan to take part in its production.
We will remind, on Wednesday, Deputy Minister of Health Alexei Kuznetsov said that the vaccine against coronavirus infection, developed at the Gamaleya Research Center for Microbiology and Epidemiology, is being registered with the Russian Ministry of Health. Earlier, the head of the Ministry of Health, Mikhail Murashko, reported that, according to plans, the first vaccine could be registered following the results of two phases of clinical trials in early August. And the third phase of testing will be carried out on a wider circle of volunteers in parallel with the introduction of the vaccine into civilian circulation.